Citadel Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Citadel Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,586	Closed	-$3.75K	–	15592
2023 Q2	$3.75K	Buy	24,586 +24,410	+13,869%	+$3.8K	﹤0.01%	13661
2023 Q1	$25	Sell	176 -110,384	-100%	-$17.7K	﹤0.01%	14616
2022 Q4	$13.3K	Sell	110,560 -2	-0%	–	﹤0.01%	13455
2022 Q3	$20K	Buy	110,562 +5,767	+6%	+$3.1K	﹤0.01%	12083
2022 Q2	$185K	Sell	104,795 -89,374	-46%	-$201K	﹤0.01%	10792
2022 Q1	$584K	Sell	194,169 -249,927	-56%	-$669K	﹤0.01%	9024
2021 Q4	$1.65M	Buy	+444,096	New	+$2.6M	﹤0.01%	6673
2021 Q3	–	Sell	-55,680	Closed	-$782K	–	14966
2021 Q2	$968K	Sell	55,680 -11,642	-17%	-$212K	﹤0.01%	8452
2021 Q1	$1.29M	Sell	67,322 -551,097	-89%	-$10.1M	﹤0.01%	7480
2020 Q4	$10.8M	Sell	618,419 -697,472	-53%	-$8.35M	﹤0.01%	2546
2020 Q3	$14M	Buy	+1,315,891	New	+$13.5M	﹤0.01%	1908

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Citadel Advisors's HGEN Position: Q3 2023 in Review

Citadel Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 24,586 shares — an estimated $3.75K sold.

Citadel Advisors first reported a position in HGEN in Q3 2020 and held it in 11 quarters. The position peaked at $14M in Q3 2020. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Citadel Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 24,586 HUMANIGEN, INC. shares in Q3 2023, an estimated $3.75K.
Citadel Advisors first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 11 quarters.
Citadel Advisors's HUMANIGEN, INC. position peaked at $14M in Q3 2020.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.